F-10POS: Oncolytics Biotech Withdraws Unsold Securities from Registration
Post-Effective Amendment to Registration Statement
Oncolytics Biotech Inc. files a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements, updating the effectiveness date for remaining registrations.
Summary
- Oncolytics Biotech Inc. has filed a post-effective amendment to several of its F-10 registration statements.
- The primary purpose of this filing is to withdraw and deregister any securities that were registered but not sold under these previous statements.
- The filing also revises the designated effectiveness date and time for the remaining registrations to April 8, 2026, at 4:30 p.m. Eastern time.
- This action pertains to multiple registration statements filed between 2007 and 2024, covering various securities including units, common shares, subscription receipts, warrants, and debt securities.
- No other changes have been made to the registration statements as previously amended.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it indicates that previous attempts to sell registered securities were not fully successful, leading to their withdrawal.
Future Outlook
The filing primarily concerns the administrative withdrawal of previously registered but unsold securities and the adjustment of effectiveness dates for remaining registrations. It does not contain forward-looking financial guidance.
Industry Context
StockSavvy.ai notes that this filing is a procedural administrative action related to past capital-raising efforts. It does not reflect current operational performance or future strategic direction, but rather the conclusion of previous registration processes.
Stakeholder Impact
- Shareholders: This filing does not directly impact current shareholders' holdings but clarifies the status of previously registered securities.
- Investors: Potential investors should note that certain previously registered securities are no longer available for sale by the company.
Next Steps
- The withdrawal of unsold securities from registration is now effective.
- The revised effectiveness date for remaining registrations is April 8, 2026.
Key Dates
| Date | Description |
|---|---|
| 2007-02-02 | Initial filing date for Registration Statement on Form F-10 (File No. 333-140460). |
| 2007-02-08 | Initial filing date for Registration Statement on Form F-10 (File No. 333-140529). |
| 2008-06-06 | Initial filing date for Registration Statement on Form F-10 (File No. 333-151513). |
| 2010-06-02 | Initial filing date for Registration Statement on Form F-10 (File No. 333-167250). |
| 2012-06-21 | Initial filing date for Registration Statement on Form F-10 (File No. 333-182260). |
| 2014-07-25 | Initial filing date for Registration Statement on Form F-10 (File No. 333-197633). |
| 2018-04-25 | Initial filing date for Registration Statement on Form F-10 (File No. 333-224432). |
| 2020-06-08 | Initial filing date for Registration Statement on Form F-10 (File No. 333-239025). |
| 2022-06-10 | Initial filing date for Registration Statement on Form F-10 (File No. 333-265510). |
| 2024-07-25 | Initial filing date for Registration Statement on Form F-10 (File No. 333-281009). |
| 2026-04-06 | Date of filing of Post-Effective Amendment No. 2. |
| 2026-04-08 | Revised effective date for remaining registrations. |
Keywords
Oncolytics Biotech, SEC Filing, F-10 Registration Statement, Deregistration, Securities Withdrawal, Post-Effective Amendment, Capital Markets
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.